These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4855503)

  • 1. Long-term follow-up of cyclophosphamide therapy in frequent relapsing minimal lesion nephrotic syndrome.
    Chiu J; Drummond KN
    J Pediatr; 1974 Jun; 84(6):825-30. PubMed ID: 4855503
    [No Abstract]   [Full Text] [Related]  

  • 2. Remission induced by chlorambucil in steroid-responsive, frequently relapsing nephrotic syndrome that relapsed after cyclophosphamide.
    Bailey RR
    N Z Med J; 1989 Jul; 102(872):379-81. PubMed ID: 2797556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of childhood prednisone-resistant nephrotic syndrome and focal segmental glomerulosclerosis with intravenous methylprednisolone and oral alkylating agents.
    Griswold WR; Tune BM; Reznik VM; Vazquez M; Prime DJ; Brock P; Mendoza SA
    Nephron; 1987; 46(1):73-7. PubMed ID: 3600915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorambucil treatment of frequently relapsing nephrotic syndrome.
    Grupe WE; Makker SP; Ingelfinger JR
    N Engl J Med; 1976 Sep; 295(14):746-9. PubMed ID: 958261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term assessment of cyclophosphamide therapy for nephrosis in children.
    McDonald J; Murphy AV; Arneil GC
    Lancet; 1974 Oct; 2(7887):980-2. PubMed ID: 4138088
    [No Abstract]   [Full Text] [Related]  

  • 6. Pattern of response to prednisone in idiopathic, minimal lesion nephrotic syndrome as a criterion in selecting patients for cyclophosphamide therapy.
    Garin EH; Pryor ND; Fennell RS; Richard GA
    J Pediatr; 1978 Feb; 92(2):304-8. PubMed ID: 621614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linear growth of children with nephrotic syndrome: effect of alkylating agents.
    Padilla R; Brem AS
    Pediatrics; 1989 Sep; 84(3):495-9. PubMed ID: 2771553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the International study of Kidney Disease in Children.
    Lancet; 1974 Aug; 2(7878):423-7. PubMed ID: 4137139
    [No Abstract]   [Full Text] [Related]  

  • 9. [The use of chlorambucil in the nephrotic syndrome (NS) with frequent recurrences in children].
    Ciardi MR; Ginevri F; Perfumo F; Gusmano R
    Minerva Nefrol; 1979; 26(4):495-600. PubMed ID: 542219
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of the idiopathic nephrotic syndrome.
    Kleinknecht C; Broyer M; Jarde O; Guillot M
    Paediatrician; 1981; 10(5-6):382-99. PubMed ID: 7036046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term prognosis of the nephrotic syndrome in childhood.
    Schärer K; Minges U
    Clin Nephrol; 1973; 1(3):182-7. PubMed ID: 4783717
    [No Abstract]   [Full Text] [Related]  

  • 12. A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood.
    Chiu J; McLaine PN; Drummond KN
    J Pediatr; 1973 Apr; 82(4):607-13. PubMed ID: 4698337
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of childhood steroid-resistant nephrotic syndrome with pulse methylprednisolone and cyclophosphamide.
    Sa GA; Luis JP; Mendonca E; Almeida M; Rosa FC
    Pediatr Nephrol; 1996 Apr; 10(2):250. PubMed ID: 8703725
    [No Abstract]   [Full Text] [Related]  

  • 14. Beneficial effect of second courses of cytotoxic therapy in children with minimal change nephrotic syndrome.
    Jones DP; Stapleton FB; Roy S; Wyatt RJ
    Pediatr Nephrol; 1988 Jul; 2(3):291-5. PubMed ID: 3153028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide in the treatment of childhood nephrotic syndrome.
    Wiggelinkhuizen J; McDonald R; Kaschula RO
    S Afr Med J; 1972 Sep; 46(39):1417-23. PubMed ID: 4642675
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence.
    Arbeitsgemeinschaft für Pädiatrische Nephrologie
    N Engl J Med; 1982 Feb; 306(8):451-4. PubMed ID: 7035953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experiences with cytotoxic drugs in therapy of the nephrotic syndrome].
    Brandis M; Krohn HP; Hanke K; Brodehl J
    Monatsschr Kinderheilkd (1902); 1977 May; 125(5):566-8. PubMed ID: 876240
    [No Abstract]   [Full Text] [Related]  

  • 18. Chlorambucil in steroid-dependent nephrotic syndrome.
    Grupe WE
    J Pediatr; 1973 Apr; 82(4):598-606. PubMed ID: 4121460
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term follow-up in children with steroid-resistant nephrotic syndrome.
    Besbas N; Topaloglu R; Saatci O; Bakkaloglu A
    Clin Pediatr (Phila); 1992 May; 31(5):283-8. PubMed ID: 1582094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of the nephrotic syndrome.
    Linshaw MA; Gruskin AB
    Clin Pediatr (Phila); 1974 Jan; 13(1):45-51. PubMed ID: 4588668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.